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ABSTRACT
INTRODUCTION
The study of mitosis and nuclear division in
Saccharomyces cerevisiae has been hindered by the
lack of an agent suitable for the specific disruption
of the mitotic apparatus. Recently, Lederberg
and Stetten (1) showed that very high concentra-
tions of the antimitotic drug Colcemid (N-methyl
N-deacetyl colchicine) were effective in arresting
the growth of the fission yeast, Schizosaccharomyces
pombe. These investigators further noted that
colchicine failed to inhibit the growth of S .
pombe, and that neither Colcemid nor colchicine
arrested the growth of a number of other species
of yeast, including S. cerevisiae. The current study
was undertaken to examine the basis of the in-
sensitivity of S. cerevisiae to Colcemid and colchi-
cine, with the hope : (a) that conditions could be
established in which mitosis was inhibited ; and
(b) that the colchicine alkaloids might serve as
Under restricted culture conditions, the growth and division of Saccharomyces cerevisiae was
inhibited by the antimitotic drug Colcemid ; in contrast, the related drug colchicine had no
effect. The difference in the sensitivity of yeast to these two agents was not dependent on
their ability to permeate the cell but rather reflected an inherent difference in the affinity
of the two drugs for a cellular-binding site. The binding moiety was characterized by gel
filtration as a macromolecule of approximately 110,000 mol wt with an affinity constant for
Colcemid of 0.5 X 104 liters per mole; in addition, this macromolecule was retained by
diethylaminoethyl (DEAE) ion exchangers. On the basis of these properties, the Colcemid-
binding substance in S. cerevisiae cells was provisionally identified as microtubule subunits.
affinity labels for microtubule subunits in further
studies on the mechanism of regulation of the
mitotic process in a simple eukaryote organism .
To determine whether the insensitivity of S .
cerevisiae to these antimitotic agents was due to
impermeability of the cell, and whether binding
sites for these agents existed within the cell,
tritium-labeled colchicine and Colcemid were
used . While tritiated colchicine was already
available, a method for the preparation of triti-
ated Colcemid had to be developed . Studies
using the labeled compounds indicated that
exponentially growing cultures of S. cerevisiae
were not freely permeable to Colcemid or col-
chicine, but that restricted conditions could be
found in which Colcemid was effective in pre-
venting vegetative growth . A drug-binding ac-
tivity was assayed and characterized in crude
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355extracts, and the binding constants for Colcemid
and colchicine were found to be consistent with
the concentrations required to inhibit growth in
vivo.
MATERIALS AND METHODS
Yeast Strains
S288C, a haploid strain of S. cerevisiae, and S41, a
homothallic diploid strain requiring arginine for
growth, were used in these experiments.
Growth Conditions
A supplemented minimal medium consisting of 2%
dextrose, 0.67% yeast nitrogen bases without amino
acids (Difco Labs, Detroit, Mich.), and vitamins (2)
was used routinely . When S41 was used, the medium
was supplemented with 20 mg/liter L-arginine . A rich
medium (YEP) composed of 2% dextrose, 2% bacto-
peptone, and 1 % yeast extract (Difco Labs) was used
where indicated. Cells were grown at 30 °C on a rotary
shaker in sterile flasks. Growth was monitored by
counting cells in a hemocytometer or by measuring
cell density at 600 nm with a Beckman DB spectro-
photometer (Beckman Instruments, Inc., Fullerton,
Calif.) .
Colcemid and Colchicine
Colcemid was obtained from Ciba Pharmaceutical
Co. (Summit, N. J .) and colchicine from Sigma
Chemical Co. (St. Louis, Mo.). Tritiated colchicine
(5.7 Ci/mmole) was purchased from New England
Nuclear Corp. (Boston, Mass.). Tritiated Colcemid
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(5.0 Ci/mmole) was also produced by New England
Nuclear Corp. according to the procedure described
below.
Preparation of Tritium-Labeled Colcemid
Tritiated Colcemid was prepared by methylation
of N-methyl, trimethylcolchicinic acid (NMCA) with
tritiated diazomethane in a manner similar to that
described for the preparation of tritium-labeled col-
chicine (3, 4) . The reaction products were a mixture
of Colcemid and iso-Colcemid, the positional isomer
being obtained by interchanging the methyl ether and
carbonyl groups of the tropolone ring (Fig. 1) . The
experimental conditions for the synthesis and resolu-
tion of the two tritiated isomers are given below .
Hydrolysis of Colcemid to NMCA
NMCA was prepared according to a modified
method for the production of colchiceine (5) . A 1 .0 g
sample of Colcemid was dissolved in 40 ml 0 .5 N HCl
and refluxed at 100°C for 1 hr. The cooled reaction
mixture was neutralized to pH 7.0-7.5 by the addition
of 1 .7 g NaHCO3. The yellow solution was extracted
with 100 ml CHC13 and filtered through MgSO4. The
chloroform was then taken off in vacuo . The residue
was recrystallized from 20 ml methanol and yielded
0.85 g of pale yellow needles (m. p. 135-137°C). Thin-
layer chromatography with 5% methanol in chloro-
form yielded a single spot, R f = 0.2. All thin-layer
chromatography was done on silicic acid impregnated
paper (Gelman ITLC SAF ; Gelman Instrument Co.,
Ann Arbor, Mich .) and the spots were visualized by
fluorescence quenching .
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FIGURE 1 Diagram showing reaction pathway for the synthesis of Colcemid 3H .
OCH3
COLCEMIDPreparation of Diazomethane
Diazomethane was generated by adding 4.3 g
N, N'-dimethyl-N, N'-dinitrosoterephthalamide (6)
(70% in mineral oil; Aldrich Chemical Co., Inc.,
Milwaukee, Wis.) to 10 ml 2-ethoxyethanol, 15 ml
30% sodium hydroxide, and 60 ml dichloromethane
in a distilling flask. Distillation into 30 ml dichloro-
methane in a receiving flask produced a final volume
of 70 ml diazomethane in dichloromethane solution .
The concentration of diazomethane was approxi-
mately 0.25 M as determined by benzoic acid titration .
A dichloromethane solution of diazomethane was
preferred to an ether solution because of the greater
solubility of NMCA in dichloromethane .
Methylation of NMCA to Colcemid
A 0.2 g sample of NMCA dissolved in 5 ml dichlo-
romethane was mixed with 20 ml of the dichloro-
methane solution of diazomethane at room tempera-
ture. The reaction mixture was allowed to stand 30
min after which time a ferric chloride test (7) for the
presence of NMCA was negative. Thin-layer chroma-
tography with 100% methanol yielded two spots, the
slower of which (Rf = 0.59) was coincident with
Colcemid. The faster spot (R f = 0.67) was presumed
to be iso-Colcemid. The methylation reaction favored
the production of Colcemid to iso-Colcemid in ap-
proximately a 4 : 1 ratio. This was in contrast to the
methylation of colchiceine to colchicine and isocol-
chicine in which the isocompound was favored by a
3 : 1 ratio (3).
Analysis of the New England Nuclear
Corporation Product
Crystallized NMCA was prepared as described
above and sent to New England Nuclear Corp. for
methylation with tritiated diazomethane and separa-
tion of the isomers by silica gel chromatography. The
tritiated product was returned as a 75 µg/ml
benzene:ethanol (9 : 1) solution with a specific activ-
ity of 5.0 Ci/mmole, and was stored in the dark under
nitrogen at 4°C. A 5 µl sample of the tritiated product
was added to 100 .sl of a 10 mm solution of Colcemid
in methanol, and 10 µl of this mixture was chromato-
graphed on Gelman ITLC SAF paper strips using
100% methanol as a solvent. The chromatograms
were cut transversely into 1 cm sections and eluted
individually with 1 ml methanol . The eluates were
examined at 350 nm for absorption, and 0 .5 ml of the
eluates were withdrawn for scintillation counting in
Bray's solution (8) . Fig. 2 shows that the radioactivity
peak superimposed on the absorption peak, indicating
that the radioactive product chromatographed iden-
tically with Colcemid . Since the chromatographic sys-
tem resolved Colcemid (R f = 0.59) from iso-Colcemid
(R f = 0.67) and colchicine (Rf = 0.70), it was con-
cluded that the tritiated product was not contami-
nated with these compounds. The tritiated material
had an ultraviolet spectrum identical to that of Col-
cemid and, in addition, bound to microtubule sub-
units prepared from porcine brain tissue (unpublished
results). We therefore regarded the product to be pure
Colcemid-3H.
Measurement of Uptake of Colcemid
and Colchicine
The degree to which yeast grown under different
physiological restrictions was permeable to colchicine
or Colcemid was determined by measuring the extent
to which the yeast cells excluded the drug. Cells were
harvested from cultures by centrifugation and 1 .0 vol-
ume of packed cells was resuspended in 0 .5-1.0 vol-
ume of media to obtain a slurry . 0.05 ml of 25 mm
Colcemid was added to 0.8 ml of cell slurry and the
mixture was incubated at 37 °C for 1 .5 hr with occa-
sional agitation. Samples of the incubated slurry were
taken up in 100-µl capillary tubes (Scientific Prod-
ucts, Evanston, I11.) ; the capillary tubes were then
sealed at one end with plasticine (J. L. Hammett Co.,
Cambridge, Mass .), placed in 15-m1 conical, glass
centrifuge tubes (for support), and centrifuged at
1450 g for 30 min in an IEC swinging bucket clinical
centrifuge (International Equipment Co ., Needham
Heights, Mass.) . The volume fraction of packed cells
was defined as the ratio : length of packed cells/length
of total suspension. From parallel centrifugations of the
bulk slurry, samples of the supernatant were measured
at 350 nm with a Beckman DB spectrophotometer
in order to determine the concentration of Colcemid
or colchicine. These concentrations were compared
with the values obtained for samples from tubes to
which no cells had been added . If the yeast cells were
completely impermeable to Colcemid or colchicine,
then the concentration of these drugs in the super-
natant of the cell suspensions would be significantly
higher than that in those samples to which no cells
had been added. If, on the other hand, the cells were
freely permeable, the concentration of Colcemid or
colchicine would nearly equal that of the control, but
would be slightly greater because of the volume oc-
cupied by structural elements of the cells. To establish
these relative changes in the drug concentration in the
supernatant, Blue Dextran (Pharmacia Fine Chem-
icals Inc., Uppsala, Sweden) was used as a measure
for the substances which were completely excluded
from the cell and tritiated water (2.5 X 106 dpm/g,
Packard Instrument Co., Inc., Downers Grove, Ill.)
was used as a measure for freely permeable molecules .
Blue Dextran was assayed spectrophotometrically at
600 mn and tritiated water was measured by liquid
scintillation counting .
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FIGURE 4 Thin-layer chromatography of Colcemid-3H and carrier Colcemid. (.) absorption at 350
mg, (O) radioactivity in cpm. The plots were adjusted to coincide at the height of the peak ; see text for
details.
The per cent permeability, P, of the cells to
the drugs was determined from the expression
P =
RII2o (RBD - R)
X 100 (see Appendix for
R (RBD - Rx2O)
derivation). R was defined as the ratio of the concen-
tration of drug in the supernatant of the cell slurry to
the concentration of the same amount of drug added
to an equivalent volume of buffer. RBD and RH20
denoted similar ratios for Blue Dextran and tritiated
water.
Preparation of Yeast Extracts
Exponentially growing yeast cells were harvested
from YEP by centrifugation at 3000 g for 15 min and
all subsequent procedures were carried out at 0-4°C.
The pelleted cells were washed twice in cold water,
and resuspended in 15 ml of 0 .05 M potassium phos-
phate buffer, pH 6.8, per 2 g packed cells. The suspen-
sion was passed twice through a French Press at 20,000
psi to rupture the cells, and the solution was then
made to 0.1 mm guanosine triphosphate (GTP) . The
broken cells were centrifuged at 15,000 g for 20 min
and the resultant supernatant was centrifuged at
100,000 g for 2 hr. The high-speed supernatant was
used immediately for binding studies . Protein con-
centration was determined by the method of Lowry
as modified by Layne (9) .
Binding of Colcemid or Colchicine to
Yeast Extracts
varying the volume of tritiated stock solution evapo-
rated. Samples were incubated for 2 hr at 37 °C in
sealed vials protected from the light . The binding re-
action was quenched by chilling the vials to 4°C.
Two methods of measuring Colcemid or colchicine
binding were used. Generally, 0 .1 ml of an incubated
sample was loaded on a Sephadex G-100 (Pharmacia
Fine Chemicals Inc .) column (0.9 X 20 cm). The col-
umn was eluted with 0.067 M potassium phosphate
buffer, pH 6.8, containing 0.1 M KCl (PK solution)
at 4°C and fractions of 0 .25 ml were collected. The
void volume was determined with a Blue Dextran
marker. The fractions were counted in Bray's solution
in a Packard Tri-Carb scintillation counter (Packard
Instrument Co.). Counting efficiency was determined
by the addition of toluene- 3H as an internal standard
and was found to be 34%.
A second method of measuring binding was also
used. In this case, 0 .1 ml of each incubation mixture
was filtered through four thicknesses of DEAE filter
paper (Whatman DE-81 Chromedia paper ; H. Reeve
Angel & Co., Inc., Clifton, N. J.) according to the
assay procedure for porcine brain microtubule pro-
tein.' The filters were washed five times with 10 ml
PK solution and the filters were counted in Bray's
solution.
A procedure using DEAE-cellulose columns (What-
man DE52) was also employed to assay binding . A 20
ml column was made in a 30 ml disposable syringe
using DE52 equilibrated in PK buffer . A 0.5 ml sam-
ple of yeast extract was applied to the column and
Small samples of tritiated Colcemid or colchicine eluted at 4 °C with a linear gradient of 0.1-1 .0 M KCl.
stock solutions in benzene: ethanol (9 : 1) were evap-
orated to dryness with a stream of nitrogen and the I Borisy, G. G. 1972. A rapid method for quantitative
dried compounds were dissolved directly in yeast ex- determination of microtubule protein using DEAE-
tract. A range of drug concentrations was obtained by cellulose filters. Anal. Biochem. In press.
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10Electron Microscopy
Isolated nuclei were prepared from exponentially
growing yeast harvested from YEP medium, and were
the gift of Dr. M. M. Bhargava. They were fixed,
embedded, and sectioned in the laboratory of Dr. H.
Ris according to previously published methods (10).
Sections were examined and micrographs taken with
a Philips 300.
RESULTS
Effect of Colcemid and Colchicine on the
Growth of S. cerevisiae
Concentrations of Colcemid and colchicine
sufficient to prevent mitosis in mammalian cells
(3) were found not to inhibit the growth of yeast.
However, under restricted growth conditions, and
at higher concentrations, Colcemid was in-
hibitory; in contrast, under the same conditions,
colchicine was without effect . The inhibition
by Colcemid was significantly affected by the
physiological state of the cells. When yeasts
which had been growing exponentially in minimal
medium were transferred to fresh minimal me-
dium containing Colcemid, growth was retarded
(Fig. 3 a). Even with 10 mm Colcemid, however,
5 10
20
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5
2
growth was not completely stopped . A more
pronounced inhibition was found when cells
from early stationary phase were used (Fig . 3 b) .
In this case, 10 mss Colcemid completely pre-
vented growth. Sensitivity to Colcemid was
greatest in cells which had been in stationary
phase for 8 hr (Fig. 3c). When stationary phase
cells were resuspended in fresh minimal media,
they reinitiated growth after a short lag . Colcemid
concentrations of I mm in the resuspension media
significantly retarded growth, and concentrations
above 2 mm were completely inhibitory. However,
if yeast were grown in YEP, Colcemid was no
longer inhibitory, even in stationary phase cul-
tures. When similar experiments were carried
out using concentrations of up to 10 mm col-
chicine, no significant inhibition was found in
cell cultures at any phase of growth .
The effect of Colcemid on the growth of S .
cerevisiae was reversible. If stationary phase cells
were incubated with 5 mm Colcemid for a period
of several hours, washed twice in minimal medium
without dextrose, and resuspended in fresh mini-
mal medium without Colcemid, growth began
after an additional lag period (Fig. 4) . Recovery
was observed after incubations of up to 7 hr
(b)
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FIGURE 3 Effect of Colcemid on the growth of S. cerevisiae at different physiological stages . S41 was
grown in minimal medium containing arginine and tested for Colcemid sensitivity at three stages of
growth. For each stage, cells were resuspended at a cell density of 1 X 106 cells/ml in fresh minimal me-
dium containing varying amounts of Colcemid . (a) Cells were harvested in logarithmic phase (1 X 107
cells/ml) and resuspended in media containing 0 mss (9), 2 mx (A), or 10 mm (X) Colcemid. (b) Cells
were harvested at the end of logarithmic growth (8 X 107 cells/ml) and resuspended in media containing
0 mm (0), 2 mm (A), or 10 mist (X) Colcemid. (c) Cells were harvested after 8 hr in stationary phase (8 .5
X 107 cells/ml) and resuspended in media containing 0 mm (0), 1 mm (LI), 2 mm (&), or 10 mx (X)
Colcemid.
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lag period after removal from Colcemid and
before growth increased with longer times of
incubation. The significance of the additional
lag is not clear, but the lag might be partially
due to the time required for Colcemid to dissociate
from cellular-binding sites (3).
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FIGURE 4 Reversibility of Colcemid inhibition.
S288C was grown to late stationary phase in minimal
medium and resuspended at a cell density of 3 X 106
cells/ml in fresh minimal media containing no Colcemid
(0), or 5 mm Colcemid (X). After 1 hr, a sample of
the cells incubated in 5 mm Colcemid was washed
and returned at the same cell density to fresh minimal
medium containing no Colcemid (o) . The arrow marks
the time at which the sample of cells was washed to
remove Colcemid.
TABLE I
Recovery of S. cerevisiae from Colcemid Inhibition
Stationary phase cells of S288C were washed and
resuspended in minimal medium containing 5 mat
Colcemid at a density of 1 X 10 6 cells/ml. At in-
tervals, samples were removed, washed twice with
minimal medium, and resuspended at the same con-
centration of cells in fresh minimal medium without
drug. The interval before the initiation of exponen-
tial growth was measured as in Fig. 4.
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The dependence of the Colcemid sensitivity of
yeast on the physiological state of the cells and
the richness of the medium suggested that the
effect of Colcemid and colchicine might be limited
by the ability of the agents to enter the cell . It
seemed possible that under conditions of starva-
tion (stationary phase cells in minimal medium),
the cell might not be able to maintain a fully
impermeable membrane; Colcemid or colchicine
might therefore penetrate the cell more readily.
A similar suggestion was supported by observa-
tions made on the effects of inhibitors of macro-
molecular synthesis in yeast (11) . The extent of
uptake of Colcemid and colchicine was therefore
measured under different physiological conditions
to determine whether changes in sensitivity to
the drugs were primarily dependent on uptake .
Thick suspensions of both exponentially growing
and stationary phase cells were equilibrated with
colchicine and Colcemid, and the amount of
drug present in the cells was determined as
described in Materials and Methods. (The
amount of drug present in the cells is a sum
of both the free compound and the compound
complexed to cellular sites ; however, the experi-
ments described below on binding of Colcemid-
3H in vitro indicated that the concentration of
cellular-binding sites was small compared to
intracellular concentrations of free drug. There-
fore, the uptake data primarily measured perme-
ability.) The results of these measurements,
given in Table II, indicated that both Colcemid
and colchicine could enter the stationary phase
cell almost as freely as water. On the other hand,
entry of Colcemid into exponential phase cells
was restricted. After 1 .5 hr, only 347 as much
Colcemid had entered the cell as compared to a
fully permeable molecule. However, the per-
meability measurement for exponentially growing
cells of 34% should be regarded as an upper limit.
Since incubation with Colcemid was carried out
in suboptimal conditions for exponential growth
(thick cell slurry), the cells used in this part of
the study may resemble cells at early stationary
phase. Since stationary phase cells are more
permeable, the 34% permeability observed in
the pseudo-exponential phase cells may be par-
tially attributed to nonideal growth conditions .
However, it does appear that the ability of
Colcemid to enter cells during active growth is
substantially reduced compared with the per-
meability of stationary phase cells; this difference
Time of incubation in 5
mm Colcemid
Lag time before the initiation
of growth
hr hr
0 1 .0
1 2 .5
4 4 .0
7 6 .5TABLE 11
Measurement of the Uptake of Colcemid and Colchicine by S . cerevisiae in
Different Physiological States
The relative permeability of Colcemid and colchicine was determined as described in
Materials and Methods . Each determination included the volume fraction of packed
cells and the ratio of concentration of the supernatant as compared with a control of
equal volume but without cells . Blue Dextran was used as a standard for a substance
completely excluded from the interior of yeast, and tritiated water was used as a stand-
ard for a substance which was freely permeable .
*P = RH2O (RBD-R) X 100.
R (RBD - Ra2o)
in permeability may account for the difference in The amount of each drug bound by the extract
the inhibition of growth by Colcemid under was assayed by Sephadex G-100 gel filtration .
varying physiological conditions . The peak of bound radioactivity eluted from the
column at a volume approximately equal to 1 .1
times the void volume, indicating that the molecu-
lar weight of the Colcemid-binding moiety was
approximately 110,000 daltons . As seen in Fig. 5,
the peak of activity was symmetrical, suggesting a
single-binding species. The tailing of counts in
the fractions after the main peak was probably a
result of dissociation of Colcemid from the bound
complex during the elution of the column .
The results from a set of equilibrium-binding
measurements for both Colcemid and colchicine
are presented in the form of a double reciprocal
plot in Fig. 6. Since the slope of a double re-
ciprocal plot is proportional to the reciprocal of
the affinity constant, it is evident from Fig. 6
that the binding of Colcemid was approximately
an order of magnitude greater than the binding
of colchicine. From the Colcemid-binding data,
an affinity constant of approximately 0 .5 X 104
liters per mole was determined . The binding
constant for colchicine, after normalizing the
colchicine specific activity to that of Colcemid,
Binding of Colcemid and Colchicine to
Yeast Extracts
While the measurements of drug uptake pre-
sented above may account for the changes in
sensitivity of S. cerevisiae to Colcemid under
various growth conditions, the results do not
provide any explanation for the lack of inhibition
by colchicine. Colchicine appeared to be as
permeable to stationary phase cells as Colcemid,
yet colchicine was without effect even at a con-
centration of 10 mm. To determine whether this
difference in growth inhibition reflected an
inherent difference in the affinity of these two
agents for a cellular-binding site, measurements
of Colcemid and colchicine binding in crude ex-
tracts were made.
The binding of Colcemid and colchicine to
freshly prepared yeast extracts over a range of
drug concentrations from 0 .01 to 0.1 mm was
carried out as described in Materials and Methods .
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Volume fraction
of packed cells
(U p)
Ratio of
supernatant
concentrations
(R)
Per cent
permeability*
(P)
A . Stationary phase cells incubated in minimal
medium without dextrose
Blue Dextran 0.437 1 .58 0
Tritiated water 0.429 1 .05 100
Colcemid 0.428 1 .11 90
Colchicine 0 .438 1 .10 91
B. Logarithmic phase cells incubated in mini-
mal medium
Blue Dextran 0 .325 1 .41 0
Tritiated water 0 .320 1 .03 100
Colcemid 0 .322 1 .28 34362
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FIGURE 5 Sephadex G-100 assay of Colcemid-binding protein. Freshly prepared yeast extract of SH
at 22.7 mg/ml protein was incubated with 0.05 mm Colcemid 3H as described in Materials and Methods
and 0.1 ml of the incubation mixture loaded on a G-100 column . A peak of bound tritiated Colcemid (0)
emerges from the column just after a peak of Blue Dextran (o).
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FIGURE 6 Double-reciprocal plot of Colcemid and
colchicine binding in yeast extract. S41 extract at
20.5 mg/ml was prepared as described in Materials
and Methods, incubated with varying concentrations
of colchicine 3H, and assayed for binding by Sephadex
G-100 chromatography. The results for Colcemid (0)
and colchicine (O) are both normalized to the specific
activity of Colcemid-3H.
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was estimated at 0 .04 X 104 liters per mole.
Therefore, it was concluded that S. cereaisiae
crude extracts contained a binding site (or sites)
which exhibited a relatively low affinity for
Colcemid and, more importantly, an even lower
affinity for colchicine. These results are con-
sistent with the in vivo observations on Colcemid
and colchicine sensitivity .
The yeast Colcemid-binding activity was further
characterized by chromatography on DEAE ion
exchangers. Because of the large number of
aspartic and glutamic residues found in amino
acid analyses of microtubule protein, it has been
determined that tubulin proteins are quite acidic
(13-19) . The acidity is the basis on which tubulin
is retained by DEAE ion exchangers, and this
property has been utilized as the basis of a method
for assaying colchicine binding' (12, 17, 19, 20) .
Samples of a yeast extract incubated with
Colcemid-3H were assayed by the DEAE filter
method and the Sephadex G-I00 column method .
A comparison of the results is presented in Table
III . Approximately 25-30 0 ) 0 of the counts ob-
served in the G-100 determinations of Colcemid
binding were retained by the DEAE filters .
This efficiency was considerably lower than that
obtained for colchicine binding (65 0 / 0) in ex-
tracts of porcine brain tissue ;' this difference was
probably due to a greater dissociation constant
of the yeast-binding moiety for Colcemid, result-ing in loss of counts from the filter stack during pH 6 .8 with PK buffer. From a parallel Sephadex
the washing procedure.
	
G-100 filtration of the same preparation, it was
The Colcemid-bound complex was retained determined that the DEAE column had been
more completely on a DEAE column than on
the filters, and could be preferentially eluted with
0.45m KC1. A mixture of yeast extract at 20.8
mg/ml protein and 0 .1 mm tritiated Colcemid
was incubated at 37 °C for 2 hr and 0.5 ml was
then loaded on a DEAE column equilibrated at
TABLE III
Comparison of DEAE Filter Paper and Sephadex
G-100 Assays for Colcemid-Binding Protein
Assay
	
Bound cpm
	
% bound
Sephadex G-100
	
28,500
	
100
DEAE filter
	
7,700
	
27
Yeast extract was incubated for 2 hr at 37 °C with
0.1 mm tritiated Colcemid and the incubation mix-
ture was used for measuring binding . The assays
were carried out as described in Materials and
Methods . The DEAE paper assay represents the
average of four sets of filters.
M
0
x
W
H
Z
22
Ui W a
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20
loaded with approximately 75,000 cpm of Colce-
mid-bound complex. The DEAE column was
then eluted with a 400 ml linear gradient of
0.1--1 .0 M KC1. In parallel experiments, it was
found that unbound Colcemid counts were
washed from the DEAE column with 0 .1 M
KCl. As shown in Fig. 7, the bound tritiated
Colcemid was retained on the DEAE column
and was eluted primarily as a single peak with
0.45 M KC1. Approximately 65,000 cpm were
recovered in this peak . This chromatographic
behavior was similar to that which has been
described for porcine brain (12) and chick embryo
brain (17, 19) microtubule protein.
DISCUSSION
Colcemid, but not colchicine, appeared to exert a
significant effect on the growth of S. cerevisiae.
This result was consistent with the observations of
Lederberg and Stetten on the drug-specific in-
0.6
0.4
0.2
40
	
60
FRACTION NUMBER
FIGURE 7 DEAE-cellulose column chromatography of yeast extract incubated with Colcemid-3H. A
30 ml column of Whatman DE-52 was equilibrated with PK buffer, pH 6 .8. The column was loaded
with 0.4 ml yeast extract at 20.8 mg/ml protein containing approximately 0 .02 mm Colcemid-3H. The
extract contained approximately 75,000 cpm of bound Colcemid as measured by Sephadex G-100 chroma-
tography. The column was eluted with a linear gradient from 0.1 to 1.0 M KCI, and 5 ml fractions col-
lected. The column was assayed by measuring the radioactivity in 0 .5 ml of each fraction .
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in the case of Colcemid, inhibition of growth
occurred only at very high concentrations (1-10
mm) . This was in contrast to the human cell lines,
strain HeLa or KB, in which a concentration of
10-7 M colchicine was sufficient to block division
(3). The Colcemid sensitivity of yeast cells ap-
peared to be dependent on their growth phase ;
cells which were growing exponentially were far
more insensitive than cells which had reached a
limit for one or more essential components in
the medium. These observations suggested that
the stationary phase cells were unable to main-
tain a completely impermeable barrier to Col-
cemid and colchicine . Evidence supporting the
hypothesis that a significant change in perme-
ability accompanied the transition from active
growth to stationary phase was provided by
direct measurements of Colcemid and colchicine
uptake; these results demonstrated that the
stationary phase cells were more permeable to
the drugs than the exponential phase cells . How-
ever, it is likely that the limited uptake of Colcemid
seen in exponential phase cells was an overesti-
mate since the cells no longer grew optimally
in the thick suspension used for assaying per-
meability. Nevertheless, the change in permeabil-
ity does seem to account for the change in Col-
cemid sensitivity in vivo.
In stationary phase cells, a concentration of I
mm Colcemid was found to inhibit the growth
rate by 50%. Measurements of the Colcemid
binding of cell extracts and analysis of the data
by a double-reciprocal plot gave an estimate of
0.2 mm for the dissociation constant of the bind-
ing protein. This compares to the value of 0.25
/LM for the dissociation constant of the colchicine-
binding protein in strain KB cells (3), and is
consistent with the relative concentrations of
Colcemid or colchicine required to inhibit
growth in yeast and human cells. If one assumes
that the action of Colcemid involves the binding
of one Colcemid molecule per binding-protein
molecule, then 50% of the protein would have
bound Colcemid at a concentration of 0 .2 mm.
Thus, the measurements on stationary phase cells
of Colcemid binding in vitro and of Colcemid
inhibition in vivo are in reasonable agreement
(factor of five difference). The fact that inhibition
of growth occurred with higher concentrations of
Colcemid than estimated from the in vitro bind-
ing studies may indicate that the effective con-
centration of Colcemid in the yeast cells was
364
somewhat lower than the concentration measured .
This observation may be accounted for by the
compartmentalization of karyokinesis in yeast
cells. The mitotic apparatus in yeast is entirely
intranuclear (21), and the nuclear envelope does
not break down during division . It is not known
whether the site of action of Colcemid in yeast
cells is in the cytoplasm, nucleus, or both, but
one might suggest that the effective concentration
of Colcemid in yeast cells is only the intranuclear
amount. Our data cannot discriminate between
Colcemid in the cytoplasm and that in the nu-
cleus. However, if one assumes that the nucleus
is the site of action of Colcemid, the measured
permeability of 90% is consistent with the hy-
pothesis that the cell membrane is wholly per-
meable while the nuclear envelope is only partially
permeable; this difference in permeability would
account for the intranuclear concentration of
Colcemid being lower than that measured for the
whole cell. An alternative possibility is that
more
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than 50 % of the microtubule subunits
must be bound with Colcemid in order for growth
to be inhibited. The lack of colchicine inhibition
of growth can be attributed to the much lower
affinity of the binding protein for colchicine.
It is believed that colchicine (and Colcemid)
are specific affinity labels for microtubule protein
(22, 23) . It is therefore reasonable to tentatively
assume that the Colcemid-binding macromole-
cule in yeast is microtubule protein . The stronger
binding affinity of Colcemid relative to colchicine
in the yeast system is consistent with the reports
of others on the more potent inhibitory effect of
Colcemid on cell division in S. pombe (1) and sea
urchin eggs (24), and on ciliary regeneration in
Tetrahymena (25) . The Colcemid-binding moiety
in yeast has a molecular weight of approximately
110,000 daltons and is acidic in nature as judged
by DEAE ion exchange chromatography . These
properties are characteristic of the colchicine-
binding protein in human cells, strain KB (22),
sea urchin eggs (26), brain tissue (12, 23), neuro-
blastoma cells (20), and sea urchin sperm tails
(27).
Another line of argument which supports the
identification of the Colcemid-binding macro-
molecules in yeast as microtubule subunits is
the rough correlation between the number of
microtubules observed in S. cerevisiae nuclei and
the amount of Colcemid-binding activity . Fig. 8
shows electron micrographs of sections through
three nuclei isolated by Dr . M. M. Bhargava (10) .
Microtubule profiles in both longitudinal andFIGURE 8 Electron micrographs of sections through a
pellet of isolated yeast nuclei . a, b, and c are thin sec-
tions showing bundles of microtubules in longitudinal
and cross-section (arrows). Approximately 40-80
microtubules can be counted in these sections . Scale,
0.5 Mm. X 37,000.
cross-section are commonly observed in random
sections ; between 40 and 80 microtubules are
found per nucleus. Presumably, serial section
data would show that the actual number of
microtubules per nucleus would be slightly
higher than these figures. Assuming that there
are sufficient subunits to make 60 microtubules
of 1 µm length (equal to one-half the nuclear
diameter), one can calculate that there would be
approximately 0.018 pg of microtubule protein
per nucleus; this amount would constitute ap-
proximately 2.4% of the nuclear protein and
0.18% of the total cellular protein (10) . Assuming
that all the microtubule subunits are recovered in
the high-speed supernatant of yeast homogenates
(which contains approximately 507 of the total
cell protein), microtubule protein would comprise
0.36% of the extract protein.
From the intercept of the double-reciprocal
plot in Fig. 6, the number of Colcemid-binding
sites can be determined. Assuming that the binding
sites are dimer subunits of 110,000 mol wt and
that they have one molecule of Colcemid bound
per dimer (12), one can calculate that Colcemid-
binding protein is 0.6 % by weight of the total
extract protein. This is in good correspondence
with the figure of 0.367 calculated from the
estimate of the numbers of microtubules per
nucleus.
In conclusion, this study has demonstrated the
existence of Colcemid-binding activity in S.
cerevisiae. The affinity of the binding moiety for
an analog of colchicine, its molecular weight of
110,000 and its retention properties on DEAE ion
exchangers all suggest that the Colcemid-binding
moiety may be provisionally identified as micro-
tubule subunits. The correlation between the
amount of binding activity and the number of
microtubules observed in yeast nuclei also sup-
ports this conclusion . Further experiments are in
progress to isolate and purify this protein, and
to establish its role in the growth and division
of yeast.
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APPENDIX
Permeability, p, is defined as the ratio Ci/C,,
where Ci is the concentration of compound inside
the cell and Ce is the concentration external to the
cell. The distribution of a compound external and
internal to cells is governed by the following condi-
tion for the conservation of mass :
CV = C'V' + CiVi
	
(1)
where V is the total suspension volume, Ve is the
volume external to cells, and Vi is the volume
internal to cells ; Ce and Ci are, respectively, the
concentrations of compound external and internal
to the cells, and C is the concentration of com-
pound that would result if a sample of drug equal
to that added to the cell slurry is added to an
equivalent volume of media . Ce is experimentally
measured as the concentration of drugs in the
supernatant of the cell suspension after packing the
cells by centrifugation. Defining the ratio of super-
natant concentrations as R = Ce/C and dividingEquation 1 by VC, we obtain:
	
Combining Equations 3 and 4, we obtain
1/R = ve + pvi,
	
(2)
where Ue and vi are, respectively, the volume frac-
tions external and internal to the cells. For Blue
Dextran, p = 0 and
1/RBD = ve .
For tritiated water, p = 1 and
(3)
1 /RH2o = VI + Vi'
	
(4)
Hence,
1/R = 1/RBD +p
(RH2o RBD)
	
(6)
or, per cent permeability, P, is given as
P _ RH2 o(RBD - R) X 100.
	
(7)
R(RBD - RH2o)
vi = 1/RH2o - 1/RBD . (5)
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